Sun Gui-Xiang, Su Yong, Li Ying, Zhang Ya-Feng, Xu Li-Chun, Zu Mao-Heng, Huang Shui-Ping, Zhang Jin-Peng, Lu Zhao-Jun
Department of Public Health, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China.
Department of Interventional Radiology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China.
Exp Ther Med. 2016 Mar;11(3):811-817. doi: 10.3892/etm.2016.2981. Epub 2016 Jan 12.
Membranous obstruction of the inferior vena cava (MOVC) is a common type of Budd-Chiari syndrome. However, the pathogenesis of MOVC has not been fully elucidated. Recent studies demonstrated that microRNAs (miRNAs or miRs) are involved in multiple diseases. To the best of our knowledge, specific changes in the expression of miRNAs in MOVC patients have not been previously assessed. The present study used a microarray analysis, followed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) validation, with the aim to access the miRNA expression levels in the plasma of 34 MOVC patients, compared with those in healthy controls. The results revealed a total of 16 differentially expressed miRNAs in MOVC patients. Subsequently, RT-qPCR analysis verified the statistically consistent expression of 5 selected miRNAs (miR-125a-5p, miR-133b, miR-423-5p, miR-1228-5p and miR-1266), in line with the results of the microarray analysis. These 5 miRNAs, which were described as crucial regulators in numerous biological processes and vascular diseases, may play an important role in the pathogenesis of MOVC. Bioinformatics analysis of target genes of the differentially expressed miRNAs revealed that these predicted targets were significantly enriched and involved in several key signaling pathways important for MOVC, including the ErbB, Wnt, MAPK and VEGF signaling pathway. In conclusion, miRNAs may involve in multiple signaling pathways contributing to the pathological processes of MOVC. The present study offers an intriguing new perspective on the involvement of miRNAs in MOVC; however, the precise underlying mechanisms require further validation.
下腔静脉膜性阻塞(MOVC)是布加综合征的一种常见类型。然而,MOVC的发病机制尚未完全阐明。最近的研究表明,微小RNA(miRNA或miR)参与多种疾病。据我们所知,此前尚未评估过MOVC患者中miRNA表达的具体变化。本研究采用微阵列分析,随后进行逆转录定量聚合酶链反应(RT-qPCR)验证,旨在检测34例MOVC患者血浆中的miRNA表达水平,并与健康对照者进行比较。结果显示,MOVC患者共有16种差异表达的miRNA。随后,RT-qPCR分析验证了5种选定miRNA(miR-125a-5p、miR-133b、miR-423-5p、miR-1228-5p和miR-1266)的表达在统计学上与微阵列分析结果一致。这5种miRNA在众多生物学过程和血管疾病中被描述为关键调节因子,可能在MOVC的发病机制中发挥重要作用。对差异表达miRNA的靶基因进行生物信息学分析表明,这些预测的靶标显著富集并参与了对MOVC重要的几个关键信号通路,包括表皮生长因子受体(ErbB)、Wnt、丝裂原活化蛋白激酶(MAPK)和血管内皮生长因子(VEGF)信号通路。总之,miRNA可能参与了导致MOVC病理过程的多个信号通路。本研究为miRNA参与MOVC提供了一个有趣的新视角;然而,确切的潜在机制需要进一步验证。